# A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment

> **NCT04268199** · PHASE2 · RECRUITING · sponsor: **AHS Cancer Control Alberta** · enrollment: 100 (estimated)

## Conditions studied

- Myeloma
- Myeloma Multiple

## Interventions

- **DRUG:** Bortezomib Injection

## Key facts

- **NCT ID:** NCT04268199
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-05-29
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04268199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04268199, "A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04268199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*